| 11591284 |
Compounds for the treatment of neuromuscular disorders |
Lars J. S. Knutsen, Thomas Holm Pedersen, Claus Elsborg Olesen, Marc Labelle, Paul Brian Little +3 more |
2023-02-28 |
|
| 10385028 |
Compounds for the treatment of neuromuscular disorders |
Lars J. S. Knutsen, Andrew William BROWN |
2019-08-20 |
|
| 8148404 |
Modulators of CB1 receptors |
Jean-Marie Receveur, Thomas Hoegberg, Peter Aadal Nielsen, Jean-Michel Linget, Pia Karina Noeregaard +2 more |
2012-04-03 |
|
| 8124634 |
CB1 receptor modulators |
Jean-Marie Receveur, Thomas Hoegberg, Peter Aadal Nielsen, Jean-Michel Linget, Pia Karina Noeregaard +2 more |
2012-02-28 |
|
| 7384950 |
Thienopyrimidinediones and their use in the modulation of autoimmune disease |
Rachel Heulwen Reynolds, Anthony Ingall, Rukhsana Rasul, Simon Guile |
2008-06-10 |
$5,253,000 |
| 7064126 |
Compounds |
Simon Guile, Anthony Ingall, Rukhsana Rasul |
2006-06-20 |
$10,429,000 |
| 6984644 |
Treatment of skin disorders using thieno[2,3-D]pyrimidinediones |
David Cheshire, Andrew Cooke, David Donald, Mark Furber, Matthew Perry +1 more |
2006-01-10 |
$11,289,000 |
| 6770646 |
Substituted fused pyridazinone compounds; composition and use thereof |
John Bantick, Philip Thorne, Matthew Perry |
2004-08-03 |
$15,911,000 |
| 6469014 |
Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
David Cheshire, Andrew Cooke, David Donald, Mark Furber, Matthew Perry +1 more |
2002-10-22 |
$9,564,000 |
| 6342502 |
Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases |
David Cheshire, Andrew Cooke, David Donald, Mark Furber, Matthew Perry +1 more |
2002-01-29 |
$7,875,000 |
| 6342601 |
Compounds |
John Bantick, Philip Thorne, Matthew Perry |
2002-01-29 |
$7,875,000 |
| 6306863 |
Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
David Cheshire, David Donald, Mark Furber, Matthew Perry, Richard P Harrison +1 more |
2001-10-23 |
$7,760,000 |
| 6300334 |
Thieno[2,3-d]pyrimidine-2,4-diones |
John Bantick, Matthew Perry, Philip Thorne |
2001-10-09 |
$7,964,000 |
| 6211368 |
Pyrrolo(3,4-d)pyrimidinone derivatives and their use as medicaments |
David Cheshire, David Donald, Mark Furber, Matthew Perry, Richard P Harrison +1 more |
2001-04-03 |
$19,377,000 |
| 6180635 |
Compounds |
David Cheshire, Andrew Cooke, David Donald, Mark Furber, Matthew Perry +1 more |
2001-01-30 |
$18,992,000 |
| 6166206 |
Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments |
David Cheshire, David Donald, Mark Furber, Matthew Perry, Richard P Harrison +1 more |
2000-12-26 |
$13,715,000 |
| 6143751 |
Pyridine derivatives and pharmaceutical compositions containing them |
David Cheshire, David Cladinggboel, David Hardern, Simon Christopher Hirst, Carol Manners +1 more |
2000-11-07 |
$10,243,000 |
| 6136974 |
Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments |
David Cheshire, David Donald, Mark Furber, Matthew Perry, Richard P Harrison +1 more |
2000-10-24 |
$19,623,000 |
| 6046204 |
Pyrrolo[3,4-D] pyrimidinone derivatives and their use as medicaments |
David Cheshire, David Donald, Mark Furber, Matthew Perry, Richard P Harrison +1 more |
2000-04-04 |
|
| 6028074 |
Pyrazolo[3,4-d]pyrimidineone compounds |
David Cheshire, David Donald, Philip Thorne |
2000-02-22 |
|
| 5376663 |
Macrocyclic compounds |
David Donald, David Hardern |
1994-12-27 |
$47,000 |
| 5296489 |
Immunosuppressive macrocyclic compounds |
David Donald, Mark Furber |
1994-03-22 |
$65,000 |
| 5210227 |
Immunosuppressive compounds |
Hirokazu Tanaka, David Donald |
1993-05-11 |
$266,000 |
| 5179087 |
Macrocyclic compounds |
David Donald, David Hardern, Mark Furber |
1993-01-12 |
$352,000 |
| 4851399 |
Isoquinoline derivatives and their use as anti-cancer agents |
Gordon H. Phillipps, Paul Jones |
1989-07-25 |
|
